Petros Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Petros Pharmaceuticals generated cash of -$7,626,529, which is more than the previous year. Cash used in financing activities reached the amount of $11,537,240 last year. Net change in cash is therefore $3,910,711.
Cash Flow
| 2019 | 2.53M | -71.54K | -3.10M |
|---|---|---|---|
| 2020 | -15.30M | -4.63K | 30.30M |
| 2021 | -11.86M | 0 | 18.56M |
| 2022 | -12.79M | 0 | -1.62M |
| 2023 | -7.62M | 0 | 11.53M |
PTPI Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 9.42M | 23.84M | 17.13M | 2.14M | 2.79M |
Operating activities | |||||
Net income | -8.16M | -20.03M | -8.98M | -20.58M | -32.51M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 3.41M | 5.59M | 6.87M | 6.66M | 5.29M |
Stock-based compensation expense | 417.23K | 1.19M | 1.30M | 0 | 0 |
| Deferred income tax benefit | 417.23K | 1.19M | 1.30M | 0 | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -144.13K | 515.95K | 2.54M | -2.75M | 932.88K |
Inventories | 273.61K | -835.31K | 412.74K | 728.28K | 2.55M |
Accounts payable | -93.14K | -2.75M | -1.05M | 2.22M | 2.02M |
Cash generated by operating activities | -7.62M | -12.79M | -11.86M | -15.30M | 2.53M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1 | 0 | 0 | -4.63K | -71.54K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 | -4.63K | -71.54K |
Financing activities | |||||
Common Stock Issued | 15.00M | 3K | 21.74M | 21.56M | 2.90M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -1.99M | 0 | 0 | 0 | 0 |
Repayments of term debt | -1.46M | -1.62M | -7.18M | -6.71M | -3.10M |
Cash used in financing activities | 11.53M | -1.62M | 18.56M | 30.30M | -3.10M |
Net Change In Cash | 3.91M | -14.42M | 6.70M | 14.99M | -648.31K |
Cash at end of period | 13.33M | 9.42M | 23.84M | 17.13M | 2.14M |
| Data source | Data source | Data source | Data source |